Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

被引：4
作者：
Sharma, Ashish [1 ,6 ]
Loewenstein, Anat [2 ]
Parachuri, Nikulaa [3 ]
Kumar, Nilesh [4 ]
Kuppermann, Baruch D. [5 ]
机构：
[1] Lotus Eye Hosp & Inst, Coimbatore, TN, India
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ophthalmol, Tel Aviv, Israel
[3] Sankara Eye Hosp, Dept Vitreoretina, Coimbatore, TN, India
[4] Madhavi Netralaya, Ara, Bihar, India
[5] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA USA
[6] Lotus Eye Hosp & Inst, Avinashi Rd, Coimbatore 641014, TN, India
来源：
JOURNAL OF VITREORETINAL DISEASES | 2023年 / 7卷 / 06期
关键词：
biosimilar; switch; retina; anti-VEGF;
D O I：
10.1177/24741264231202080
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 476
页数：3
相关论文
共 50 条
[31]   Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery [J].
Andreanos, Konstantinos ;
Petrou, Petros ;
Kymionis, George ;
Papaconstantinou, Dimitrios ;
Georgalas, Ilias .
BMC OPHTHALMOLOGY, 2017, 17 :238
[32]   Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy [J].
Wallsh, Josh ;
Sharareh, Behnam ;
Gallemore, Ron .
CLINICAL OPHTHALMOLOGY, 2016, 10 :947-954
[33]   Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion [J].
Qin, Hai-Feng ;
Shi, Fan-Jun ;
Zhang, Chao-Yang ;
Luo, Da-Wei ;
Qin, Shi-Yue ;
Wu, Jing ;
Xie, Hai ;
Zhang, Jing-Ting ;
Qiu, Qing-Hua ;
Liu, Kun ;
Xu, Guo-Tong ;
Xu, Guo-Xu ;
Zhang, Jing-Fa .
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (08) :1296-1304
[34]   New Anti-VEGF Drugs in Ophthalmology [J].
Campa, Claudio .
CURRENT DRUG TARGETS, 2020, 21 (12) :1194-1200
[35]   Chances and risks of anti-VEGF therapy [J].
Ziemssen, F. ;
Heiduschka, P. ;
Peters, S. ;
Grisanti, S. ;
Schraermeyer, U. .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (09) :770-778
[36]   Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study [J].
van Poecke, W. H. A. ;
Hooi, N. E. F. ;
Mossel, T. K. ;
Hermans, M. A. W. ;
van Daele, P. L. A. ;
Bunnik, E. M. ;
Brkic, Z. ;
Sels, L. K. ;
Thiadens, A. A. H. J. ;
van Hagen, P. M. ;
van Laar, J. A. M. ;
Rombach, S. M. .
BMC IMMUNOLOGY, 2025, 26 (01)
[37]   Effect of anti-VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy [J].
Su, Zheng Zhe Steven ;
Ang, Bryan Chin Hou ;
Balne, Praveen Kumar ;
Tun, Sai Bo Bo ;
Htoon, Hla Myint ;
Schmetterer, Leopold ;
Barathi, Veluchamy Amutha ;
Agrawal, Rupesh .
ACTA OPHTHALMOLOGICA, 2024, 102 (06) :e926-e934
[38]   RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION The Rubeosis Anti-VEGF (RAVE) Trial [J].
Brown, David M. ;
Wykoff, Charles C. ;
Wong, Tien P. ;
Mariani, Angeline F. ;
Croft, Daniel E. ;
Schuetzle, Karri L. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (09) :1728-1735
[39]   Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment? [J].
Georgiadis, Odysseas ;
Kabanarou, Stamatina A. ;
Batsos, Georgios ;
Feretis, Elias ;
Xirou, Tina .
CASE REPORTS IN OPHTHALMOLOGY, 2014, 5 (02) :231-238
[40]   Prognostic Value of Photopic Negative Response in Retinal Vein Occlusion after Anti-VEGF treatment [J].
Park, Tae Kwann ;
Hyun, Joo ;
An, SangIl ;
Ohn, Young-Hoon .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345